Cargando…
Identification of a therapeutic target using molecular sequencing for treatment of recurrent uterine serous adenocarcinoma
Uterine serous adenocarcinoma is a rare but highly malignant form of endometrial cancer, comprising over 50% of recurrences and deaths from endometrial cancer. We report a case of a 68-year old woman with recurrent uterine serous adenocarcinoma who underwent molecular testing and genetic sequencing...
Autores principales: | Musselman, Kelsey, Glynn, Shannon, Mosquera, Juan Miguel, Elemento, Olivier, Sboner, Andrea, Beltran, Himisha, Holcomb, Kevin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6411491/ https://www.ncbi.nlm.nih.gov/pubmed/30906838 http://dx.doi.org/10.1016/j.gore.2019.01.013 |
Ejemplares similares
-
Molecular Evaluation of Low-grade Low-stage Endometrial Cancer With and Without Recurrence
por: Matrai, Cathleen E., et al.
Publicado: (2022) -
The Role of Next-Generation Sequencing in Precision Medicine: A Review of Outcomes in Oncology
por: Morash, Margaret, et al.
Publicado: (2018) -
Uterine Serous Adenocarcinoma in an Elderly Postmenopausal Woman: Clinically Misdiagnosed as Uterine Cervix Cancer
por: Hong, Jeong-A, et al.
Publicado: (2015) -
In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma
por: El-Sahwi, K, et al.
Publicado: (2010) -
Evolution of structural rearrangements in prostate cancer intracranial metastases
por: Khani, Francesca, et al.
Publicado: (2023)